S. Daignault

Persister state-directed transitioning and vulnerability in melanoma

Samantha J. Stehbens, D. Schadendorf, J. Becker, 2020, Nature Communications.

Functional melanoma cell heterogeneity is regulated by MITF-dependent cell-matrix interactions

Samantha J. Stehbens, N. Matigian, N. Haass, 2020 .

Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer

Esha T. Shah, Melissa J. Davis, N. Haass, 2016, Oncotarget.

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

V. Bonazzi, N. Haass, B. Gabrielli, 2019, Molecular oncology.

Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells.

Wolfgang Weninger, N. Haass, B. Gabrielli, 2016, The Journal of investigative dermatology.

Enforced polarization of melanoma cells towards a JARID1B-high phenotype exhausts tumour fitness

D. Schadendorf, M. Herlyn, N. Haass, 2017 .

Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo

N. Haass, R. Sturm, B. Gabrielli, 2018, Clinical Cancer Research.

Functional melanoma cell heterogeneity is regulated by MITF-dependent cell-matrix interactions

N. Matigian, W. Weninger, R. Jurek, 2020 .